A Detailed Analysis of the Eye Care Supplement Market Based on the Growing Prevalence of Eye Disorders, and the Frequent Introduction of New Products
Industry: Healthcare
Published Date: January-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 147
Report ID: PMRREP33738
1. Executive Summary
1.1. Global Eye Care Supplement Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Ingredient Lifecycle Analysis
2.4. Eye Care Supplement Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Formulations
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Eye Care Supplement Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Eye Care Supplement Market Outlook: Ingredient
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Ingredient, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2023 - 2030
3.3.3.1. Lutein and Zeaxanthin
3.3.3.2. Omega-3 Fatty Acids
3.3.3.3. Antioxidants
3.3.3.4. Coenzyme Q10
3.3.3.5. Flavonoids
3.3.3.6. Alpha-lipoic Acid
3.3.3.7. Astaxanthin
3.3.3.8. Others
3.4. Market Attractiveness Analysis: Ingredient
3.5. Global Eye Care Supplement Market Outlook: Indication
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Indication, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
3.5.3.1. Age-related Macular Degeneration (AMD)
3.5.3.2. Cataract
3.5.3.3. Dry Eye syndrome
3.5.3.4. Inflammation
3.5.3.5. Others
3.6. Market Attractiveness Analysis: Indication
3.7. Global Eye Care Supplement Market Outlook: Formulation
3.7.1. Introduction / Key Findings
3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Formulation, 2018 - 2022
3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Formulation, 2023 - 2030
3.7.3.1. Tablets
3.7.3.2. Capsules
3.7.3.3. Powder
3.7.3.4. Softgels
3.7.3.5. Liquid
3.8. Market Attractiveness Analysis: Formulation
3.9. Global Eye Care Supplement Market Outlook: Distribution Channel
3.9.1. Introduction / Key Findings
3.9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Distribution Channel, 2018 - 2022
3.9.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
3.9.3.1. Retail Pharmacies
3.9.3.2. Hospital pharmacies
3.9.3.3. Online pharmacies
3.9.3.4. Ophthalmic Stores
3.10. Market Attractiveness Analysis: Distribution Channel
4. Global Eye Care Supplement Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia & Pacific
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Eye Care Supplement Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Ingredient
5.3.3. By Indication
5.3.4. By Formulation
5.3.5. By Distribution Channel
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2023 - 2030
5.5.1. Lutein and Zeaxanthin
5.5.2. Omega-3 Fatty Acids
5.5.3. Antioxidants
5.5.4. Coenzyme Q10
5.5.5. Flavonoids
5.5.6. Alpha-lipoic Acid
5.5.7. Astaxanthin
5.5.8. Others
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
5.6.1. Age-related Macular Degeneration (AMD)
5.6.2. Cataract
5.6.3. Dry Eye syndrome
5.6.4. Inflammation
5.6.5. Others
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Formulation, 2023 - 2030
5.7.1. Tablets
5.7.2. Capsules
5.7.3. Powder
5.7.4. Softgels
5.7.5. Liquid
5.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
5.8.1. Retail Pharmacies
5.8.2. Hospital pharmacies
5.8.3. Online pharmacies
5.8.4. Ophthalmic Stores
5.9. Market Attractiveness Analysis
6. Europe Eye Care Supplement Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Ingredient
6.3.3. By Indication
6.3.4. By Formulation
6.3.5. By Distribution Channel
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Turkey
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2023 - 2030
6.5.1. Lutein and Zeaxanthin
6.5.2. Omega-3 Fatty Acids
6.5.3. Antioxidants
6.5.4. Coenzyme Q10
6.5.5. Flavonoids
6.5.6. Alpha-lipoic Acid
6.5.7. Astaxanthin
6.5.8. Others
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
6.6.1. Age-related Macular Degeneration (AMD)
6.6.2. Cataract
6.6.3. Dry Eye syndrome
6.6.4. Inflammation
6.6.5. Others
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Formulation, 2023 - 2030
6.7.1. Tablets
6.7.2. Capsules
6.7.3. Powder
6.7.4. Softgels
6.7.5. Liquid
6.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
6.8.1. Retail Pharmacies
6.8.2. Hospital pharmacies
6.8.3. Online pharmacies
6.8.4. Ophthalmic Stores
6.9. Market Attractiveness Analysis
7. East Asia Eye Care Supplement Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Ingredient
7.3.3. By Indication
7.3.4. By Formulation
7.3.5. By Distribution Channel
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2023 - 2030
7.5.1. Lutein and Zeaxanthin
7.5.2. Omega-3 Fatty Acids
7.5.3. Antioxidants
7.5.4. Coenzyme Q10
7.5.5. Flavonoids
7.5.6. Alpha-lipoic Acid
7.5.7. Astaxanthin
7.5.8. Others
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
7.6.1. Age-related Macular Degeneration (AMD)
7.6.2. Cataract
7.6.3. Dry Eye syndrome
7.6.4. Inflammation
7.6.5. Others
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Formulation, 2023 - 2030
7.7.1. Tablets
7.7.2. Capsules
7.7.3. Powder
7.7.4. Softgels
7.7.5. Liquid
7.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
7.8.1. Retail Pharmacies
7.8.2. Hospital pharmacies
7.8.3. Online pharmacies
7.8.4. Ophthalmic Stores
7.9. Market Attractiveness Analysis
8. South Asia & Oceania Eye Care Supplement Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Ingredient
8.3.3. By Indication
8.3.4. By Formulation
8.3.5. By Distribution Channel
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2023 - 2030
8.5.1. Lutein and Zeaxanthin
8.5.2. Omega-3 Fatty Acids
8.5.3. Antioxidants
8.5.4. Coenzyme Q10
8.5.5. Flavonoids
8.5.6. Alpha-lipoic Acid
8.5.7. Astaxanthin
8.5.8. Others
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
8.6.1. Age-related Macular Degeneration (AMD)
8.6.2. Cataract
8.6.3. Dry Eye syndrome
8.6.4. Inflammation
8.6.5. Others
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Formulation, 2023 - 2030
8.7.1. Tablets
8.7.2. Capsules
8.7.3. Powder
8.7.4. Softgels
8.7.5. Liquid
8.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
8.8.1. Retail Pharmacies
8.8.2. Hospital pharmacies
8.8.3. Online pharmacies
8.8.4. Ophthalmic Stores
8.9. Market Attractiveness Analysis
9. Latin America Eye Care Supplement Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Ingredient
9.3.3. By Indication
9.3.4. By Formulation
9.3.5. By Distribution Channel
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2023 - 2030
9.5.1. Lutein and Zeaxanthin
9.5.2. Omega-3 Fatty Acids
9.5.3. Antioxidants
9.5.4. Coenzyme Q10
9.5.5. Flavonoids
9.5.6. Alpha-lipoic Acid
9.5.7. Astaxanthin
9.5.8. Others
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
9.6.1. Age-related Macular Degeneration (AMD)
9.6.2. Cataract
9.6.3. Dry Eye syndrome
9.6.4. Inflammation
9.6.5. Others
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Formulation, 2023 - 2030
9.7.1. Tablets
9.7.2. Capsules
9.7.3. Powder
9.7.4. Softgels
9.7.5. Liquid
9.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
9.8.1. Retail Pharmacies
9.8.2. Hospital pharmacies
9.8.3. Online pharmacies
9.8.4. Ophthalmic Stores
9.9. Market Attractiveness Analysis
10. Middle East & Africa Eye Care Supplement Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Ingredient
10.3.3. By Indication
10.3.4. By Formulation
10.3.5. By Distribution Channel
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2023 - 2030
10.5.1. Lutein and Zeaxanthin
10.5.2. Omega-3 Fatty Acids
10.5.3. Antioxidants
10.5.4. Coenzyme Q10
10.5.5. Flavonoids
10.5.6. Alpha-lipoic Acid
10.5.7. Astaxanthin
10.5.8. Others
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
10.6.1. Age-related Macular Degeneration (AMD)
10.6.2. Cataract
10.6.3. Dry Eye syndrome
10.6.4. Inflammation
10.6.5. Others
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Formulation, 2023 - 2030
10.7.1. Tablets
10.7.2. Capsules
10.7.3. Powder
10.7.4. Softgels
10.7.5. Liquid
10.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
10.8.1. Retail Pharmacies
10.8.2. Hospital pharmacies
10.8.3. Online pharmacies
10.8.4. Ophthalmic Stores
10.9. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Omega-3 Fatty Acids
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. The Nature's Bounty Co.
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. Pfizer Inc.
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. Vitabiotics Ltd.
11.3.3.1. Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Bausch & Lomb
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Kemin Industries, Inc.
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. Amway International
11.3.6.1. Overview
11.3.6.2. Segments and Product
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. EyeScience
11.3.7.1. Overview
11.3.7.2. Segments and Product
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. Wellbeing Nutrition
11.3.8.1. Overview
11.3.8.2. Segments and Product
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. Nutrivein
11.3.9.1. Overview
11.3.9.2. Segments and Product
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
11.3.10. ZeaVision LLC
11.3.10.1. Overview
11.3.10.2. Segments and Product
11.3.10.3. Key Financials
11.3.10.4. Market Developments
11.3.10.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations